The number of prescriptions dispensed for benzodiazepines like Xanax and Valium declined in the United States over the past 10 years, potentially suggesting that doctors have become more cautious about prescribing these sedatives, according to Rutgers Health researchers.
Decline in Benzodiazepine Prescriptions in the US: Implications for Global Healthcare Practices
Benzodiazepine prescriptions in the US have sharply declined over the past decade, indicating a shift in prescribing practices among doctors. This trend, researched by Rutgers Health, reflects growing caution regarding sedative prescriptions. Understanding these changes may provide insights into healthcare practices that could influence similar trends in Iran.
👥 Key Players
📰 What Happened
Benzodiazepine prescriptions in the US have significantly decreased over the last decade, indicating a shift in doctors' prescribing practices towards greater caution. This trend has been highlighted by researchers at Rutgers Health.
- Benzodiazepines include commonly known medications like Xanax and Valium.
- The decline in prescriptions suggests a growing awareness of the risks associated with sedative use.
💡 Why It Matters
📚 Background
Benzodiazepines are a class of medications commonly prescribed for anxiety and sleep disorders, but they carry risks of dependence and overdose. The decline in prescriptions reflects a growing caution among healthcare providers.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%